Atara Biotherapeutics (ATRA)
(Delayed Data from NSDQ)
$0.53 USD
-0.02 (-2.91%)
Updated May 10, 2024 04:00 PM ET
After-Market: $0.53 0.00 (0.02%) 7:58 PM ET
2-Buy of 5 2
F Value C Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $-0.33 | 0.00% |
Earnings Summary
For their last quarter, Atara Biotherapeutics (ATRA) reported earnings of -$0.23 per share, beating the Zacks Consensus Estimate of $-0.37 per share. This reflects a positive earnings surprise of 37.84%. Look out for ATRA's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of -$0.33 per share, reflecting a year-over-year increase of 51.47%.
Earnings History
Price & Consensus
Zacks News for ATRA
Femasys Inc. (FEMY) Reports Q1 Loss, Misses Revenue Estimates
ATRA: What are Zacks experts saying now?
Zacks Private Portfolio Services